This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Fabri, P. J. Articles by Ruberg, R. L. Search for Related Content PubMed PubMed Citation Articles by Fabri, P. J. Articles by Ruberg, R. L. Social Bookmarking                         What's this?

Clinical Effect of Nonthrombotic Total Parenteral Nutrition Catheters

Ohio State University Hospitals, College of Medicine, Columbus, Ohio

Jay M. Mirtallo, M.S., R.PH.

Ohio State University Hospitals, College of Medicine, Columbus, Ohio

Mary Lou Ebbert, PHARM.D., R.PH.

Ohio State University Hospitals, College of Medicine, Columbus, Ohio

Kenneth A. Kudsk, M.D.

Ohio State University Hospitals, College of Medicine, Columbus, Ohio

Carla Powell, R.N.

Ohio State University Hospitals, College of Medicine, Columbus, Ohio

Robert L. Ruberg, M.D.

Ohio State University Hospitals, College of Medicine, Columbus, Ohio

Radiographic evidence of subclavian vein thrombosis has been shown to occur in 33% of total parenteral nutrition patients. This incidence can be significantly reduced to 8% when heparin is administered concomitantly in total parenteral nutrition solutions. To evaluate the thrombotic risk of a newly developed polyurethane catheter, 20 concurrent patient pairs were prospectively cannulated with either a standard polyethylene catheter plus heparin or a polyurethane catheter without heparin in a sequential statistical study. Radionuclide venograms (Tc^99m) were performed within 72 hr of catheterization, at biweeky intervals, and at termination of total parenteral nutrition administration. No patient in either group developed clinical (pain, arm swelling, collateral veins) or venogram evidence of thrombosis after catheterization during an overall cannulation period of 820 days. Use of polyurethane catheters and elimination of heparin in total parenteral solutions may be particularly important since contraindications to heparin use are common. Additionally, heparin elimination can decrease admixture work and confusion (ie, subcutaneous heparin double dosing) without increasing the risk of subclavian vein thrombosis. (Journal of Parenteral and Enteral Nutrition 8:705-707, 1984)

Journal of Parenteral and Enteral Nutrition, Vol. 8, No. 6, 705-707 (1984)
DOI: 10.1177/0148607184008006705


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C. P. W. Klerk, S. M. Smorenburg, and H. R. Buller Thrombosis Prophylaxis in Patient Populations With a Central Venous Catheter: A Systematic Review Arch Intern Med, September 8, 2003; 163(16): 1913 - 1921. [Abstract] [Full Text] [PDF]

				M. E. Andrew, P. Monagle, G. deVeber, and A. K.C. Chan Thromboembolic Disease and Antithrombotic Therapy in Newborns Hematology, January 1, 2001; 2001(1): 358 - 374. [Abstract] [Full Text] [PDF]

				T.R. Beers, J. Burnes, and C.R. Fleming Superior Vena Caval Obstruction in Patients with Gut Failure Receiving Home Parenteral Nutrition JPEN J Parenter Enteral Nutr, September 1, 1990; 14(5): 474 - 479. [Abstract] [PDF]

				K. A. Kudsk, C. Powell, J. M. Mirtallo, P. J. Fabri, and R. L. Ruberg Heparin Does Not Reduce Catheter Sepsis during Total Parenteral Nutrition JPEN J Parenter Enteral Nutr, May 1, 1985; 9(3): 348 - 349. [Abstract] [PDF]